Premium
Letter: TNFα blockers and psoriasis: a ‘reasonable paradox’ – the role of TH‐17 cells
Author(s) -
Sartini A.,
Di Girolamo M.,
Scarcelli A.,
Bertani A.,
Marzi L.,
Lasagni C.,
Merighi A.,
Villa E.
Publication year - 2014
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12705
Subject(s) - ustekinumab , psoriasis , medicine , adalimumab , crohn's disease , inflammatory bowel disease , tumor necrosis factor alpha , psoriasis area and severity index , dermatology , immune system , immunology , gastroenterology , disease